Meaning
Biological screening procedures employing modified Salmonella typhimurium strains identify point mutations caused by extractable chemical compounds leaching from plastic materials. Medical devices and food contact packaging undergo ames mutagenicity assay testing to verify that volatile additives or degradation products do not induce genetic damage. The protocol evaluates frame shifts and base pair substitutions under controlled incubation conditions.
Evaluation stops once cell toxicity levels inhibit bacterial growth, requiring secondary analytical assays for higher cytotoxicity thresholds.
Bacterial Response
Genetically engineered bacterial strains lacking histidine synthesis capability regain metabolic function only when exposed to mutagens. Extracted samples from plasticized polyvinyl chloride or polyolefin films are applied to agar plates containing trace nutrients. Growth colonies signal genetic mutation events.
Extractable Assessment
Solvents simulating food fatty acids or human blood fluids isolate plasticizer fragments and residual monomer contaminants from moulded components. Heavy processing shear degrades stabilizer packages, releasing small molecules during ames mutagenicity assay preparation. Standard datasheets for raw virgin resin rarely capture compound degradation products produced during secondary moulding operations.
Higher regrind ratios increase volatile extractables that alter bacterial mutation rates during testing.
Genotoxic Boundary
Cytotoxic responses at high extract concentrations kill test organisms before mutagenic colony formation occurs, masking genetic toxicity. Dilution series reestablish valid testing parameters by lowering compound concentration below lethal cell limits. Quantitative colony counting establishes compound safety margins for regulated medical components.
Clear test plates confirm absence of mutagenic leachable substances when performing an ames mutagenicity assay.
